Injective CEO Eric Chen met with officials from the White House, SEC, and CFTC in October 2026 to discuss advancing regulated onchain finance and tokenization of real-world assets (RWAs) in the US. Injective, registered as a transfer agent by the SEC in August 2026, can maintain official ownership records for tokenized securities, a key step for institutional adoption. The company reports over $1 billion in tokenized RWA value on its network and has also secured regulated futures trading for its INJ token. While no new approvals were announced, these engagements reflect growing regulatory openness and could reduce risks for institutional investors in DeFi markets, though regulatory outcomes remain uncertain.
Injective's INJ token trades at Rp139.970 on Pluang as of Oct 24, 2026 18:51 WIB, down 4.06% in the past day. This price contrasts with its full circulating supply of 100 million INJ and a market cap of Rp13,87 trillion, highlighting significant investor interest despite recent declines. The token's 24-hour trading volume of Rp1,5 trillion and a strong buy order activity of 95% on Pluang indicate active trading and demand amid regulatory developments.
Injective (INJ), a digital asset, traded at $7.67 as of 6:56 a.m. ET on Saturday, reflecting a 3.74% decrease over the previous 24 hours. This price movement indicates a short-term decline in investor interest or market volatility affecting INJ. Inve...
Canary Capital submitted a preliminary filing on Sept. 24 for an Injective (INJ) ETF that plans to stake at least 90% of its INJ tokens to earn rewards. The fund's daily net asset value will reflect staking rewards, but no cash rewards will be paid t...
Among the 90 largest cryptocurrencies, MemeCore (M) surged 17.03% in 24 hours, leading gains while 72 out of 90 assets declined. Other notable risers included Lighter (8.54%), Monero (5.85%), and Bitway (5.53%). Conversely, LayerZero fell the most by...
Injective (INJ) traded below the key $8.90 level on October 22, falling 7% within 24 hours. This dip puts into question a previous bullish technical scenario that required daily closes above $8.90 to remain valid. While the intraday price dropped bel...
Canary Capital proposes an Injective (INJ) ETF that reinvests staking rewards back into the fund rather than distributing cash to shareholders. The fund delegates tokens to validators on the Injective network, with staking rewards paid in INJ tokens....
